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Abstract
Purpose—To determine whether the mammographic technologist has an effect on the 
radiologists’ interpretative performance of screening mammography in community practice.
Materials and Methods—In this institutional review board approved retrospective cohort 
study, we included Carolina Mammography Registry (CMR) data from 372 radiologists and 356 
mammographic technologists from 1994 to 2009 who performed 1,003,276 screening 
mammograms. Measures of interpretative performance (recall rate, sensitivity, specificity, positive 
predictive value (PPV1), and cancer detection rate (CDR)) were ascertained prospectively with 
cancer outcomes collected from the state cancer registry and pathology reports. To determine if 
the mammographic technologist influenced the radiologists’ performance, we employed mixed 
effects logistic regression models, including a radiologist-specific random effect and taking into 
account the clustering of examinations across women, separately for screen-film mammography 
(SFM) and full field digital mammography (FFDM).
Results—Of the 356 mammographic technologists included, 343 performed 889,347 SFM 
examinations and 51 performed 113,929 FFDM examinations, and 38 performed both SFM and 
FFDM. A total of 4,328 cancers were reported for SFM and 564 cancers for FFDM. The 
technologists had a statistically significant effect on the radiologists’ recall rate, sensitivity, 
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specificity and CDR for both SFM and FFDM (p-values<0.01). For PPV1, variability by 
technologist was observed for SFM (p-value<0.0001) but not for FFDM (p-value=0.088).
Conclusion—The interpretative performance of radiologists in screening mammography varies 
substantially by the technologist performing the examination. Additional studies should aim to 
identify technologist characteristics that may explain this variation.
Introduction
Breast cancer is the most common cancer in women, excluding cancers of the skin, and is 
expected to account for an estimated 232,670 cases and 40,000 deaths in the US in 2014.(1) 
Routine screening mammography is the primary means of early breast cancer detection with 
radiologic technologists fulfilling an essential role in the mammography process. While 
routine screening mammography has proven effective in reducing breast cancer mortality(2), 
many factors lead to variability in interpretative performance by radiologists.(3–6)
Several studies have found radiologists’ gender, work patterns, post residency training, years 
of experience, specialization, and screening versus diagnostic mix influence mammography 
performance measures.(3, 7–12) It is also likely that the radiologists’ ability to interpret 
mammograms is affected by technologists who work with the radiologists. Possible sources 
of variation in radiologists’ interpretative ability may include the interface between the 
radiologist and technologist and the ability of the radiologic technologist to obtain a high 
quality image in terms of positioning, compression, and sharpness.
Prior studies have examined the performance of technologists as pre-readers or double 
readers of screening mammography in conjunction with radiologists. In general, the use of 
technologists as pre or double readers for screening mammograms led to increased cancer 
detection rates (CDR) without significantly increased recall or false positive rates.(13–17) 
To our knowledge, no studies have examined the extent of variability among radiologists’ 
screening mammography performance by the technologist performing the exam. Hence, we 
used 15 years of community based mammography data to determine whether the 
performance characteristics of screening mammography differ by technologist for screen-
film mammography (SFM) and full field digital mammography (FFDM) separately.
Material and Methods
The Carolina Mammography Registry (CMR) has collected prospective data from 
mammography facilities in North Carolina since 1994. Information includes characteristics 
of women, reason for the breast-imaging visit, breast cancer risk factors, imaging procedures 
performed, radiologist’s findings, assessments and management recommendations. These 
data are linked with the state cancer registry and pathology data to allow for calculation of 
standard performance measures including recall rate, sensitivity, specificity, positive 
predictive value of recall (PPV1), and cancer detection rate (CDR). For each mammogram 
performed at CMR participating facilities, a unique technologist code was collected. These 
technologist codes allow for the identification of technologists over time and across CMR 
participating facilities.
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The study included 1,012,491 bilateral screening mammograms among women ages 18 and 
older, with no personal history of breast cancer and no breast implants, from CMR 
participating facilities, between January 1, 1994 and December 31, 2009. We excluded 
9,215 screening mammograms in which the technologist performed fewer than 50 exams per 
year or were active for less than 6 months. This gave a total of 1,003,276 screening 
mammograms that were performed by 356 technologists, interpreted by 372 radiologists, 
and performed at 59 facilities.
Definitions
Using standard definitions, we defined a screening mammogram as a bilateral, two view 
mammogram indicated as screening by the radiologist.(18) Each mammogram interpretation 
was classified as positive or negative based on the radiologists’ Breast Imaging Reporting 
and Data System (BI-RADS) screening assessment result. We defined an exam positive for 
recall if the initial BI-RADS assessment was 0 (additional imaging required), 4 (needs 
evaluation), 5 (highly suggestive of malignancy), or 3 (probably benign) with a 
recommendation for immediate evaluation. We defined a negative interpretation as BI-
RADS of 1 (negative), 2 (benign finding), or 3 (probably benign) with no recommendation 
for immediate evaluation.(19, 20) We used data from the North Carolina Central Cancer 
Registry (NCCCR) as well as pathology data from CMR participating mammography 
facilities and the University of North Carolina at Chapel Hill’s Lineberger Comprehensive 
Cancer Center’s Rapid Case Ascertainment program to identify breast cancer cases. Women 
were considered to have breast cancer if a diagnosis of invasive carcinoma or ductal 
carcinoma in situ occurred within one year of the screening mammogram.(21) From the 
radiologists’ BI-RADS interpretation and the cancer diagnosis, each mammogram was 
classified as true positive (positive mammogram with cancer diagnosed in the follow-up 
period), false positive (positive mammogram with no cancer diagnosed in the follow-up 
period), true negative (negative mammogram with no cancer diagnosed in the follow-up 
period), or false negative (negative mammogram with cancer diagnosed in the follow-up 
period).
Information on the patient and image characteristics collected at the time of mammography 
included patient age, patient race, mammographic breast density, family history of breast 
cancer (defined as at least one first degree relative with breast cancer), history of breast 
procedure, time since last mammographic exam, and year of exam. Breast density was 
categorized by the interpreting radiologist according to the BI-RADS assessments of almost 
entirely fat, scattered fibroglandular densities, heterogeneously dense, or extremely dense.
(20)
Performance measures included recall rate, sensitivity, specificity, PPV1, and CDR of the 
screening mammogram. Recall rate was defined as the percentage of screening 
mammograms with findings interpreted as positive. Sensitivity was defined as the 
proportion of those with a positive screening mammogram interpretation among all those 
with a breast cancer diagnosis within the one-year follow-up period. Specificity was defined 
as the percentage of screening mammograms with findings interpreted as negative among all 
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patients who did not receive a breast cancer diagnosis in the follow-up period. PPV1 was 
defined as the percentage of positive mammograms that resulted in a breast cancer 
diagnosis. CDR was defined as the number of true-positive mammograms for every 1,000 
screening mammograms.
Statistical Analysis
We describe the characteristics of the mammograms included in the study, separately for 
FFDM and SFM examinations. We also provide the average number of screening 
mammograms performed per technologist by modality. In addition, we computed the mean 
performance measure and 95% confidence intervals (95%CI) for recall rate, sensitivity, 
specificity, PPV1, and CDR.
For each performance measure, we fit a mixed effects logistic regression model to evaluate 
variability across technologists. The models included both technologist-specific and 
radiologist-specific random effects. By including both the technologist-specific and 
radiologist-specific random effects, we were able to partition the variance arising from 
differences in technologists and radiologists, quantifying the variance in performance 
measures by technologist after controlling for variance arising at the radiologist level. Since 
some women had multiple examinations, we also modeled a compound symmetric residual 
variance structure to account for the fact that examinations within a woman were likely 
correlated. We assessed variation of the performance measures across technologists by 
conducting likelihood ratio tests, using the residual pseudolikelihood.(22)
This retrospective cohort study is compliant with the Health Insurance Portability and 
Accountability Act as well as approved by the Institutional Review Board with a waiver of 
consent.
Results
From 1994 to 2009 a total of 1,003,276 screening mammograms, 88.6% (n=889,347) SFM 
and 11.4% (n=113,929) FFDM, were performed (Table 1). The majority of examinations 
were performed among women ages 40–59 years. Approximately 16–18% of screening 
mammograms were performed among African-American women and 8–11% reported a 
family history of breast cancer. Breast density was similar among those with SFM and 
FFDM examinations. Of the SFM, 21% reported having a prior breast biopsy or breast 
surgery, compared with 24% in the FFDM group. The majority of women had a prior 
mammogram within 1–2 years. As expected, the number of SFM increased until the 
introduction of FFDM in CMR practices in 2003.
Overall, 372 radiologists interpreted 1,003,276 screening mammograms performed by 356 
technologists, with 343 technologists performing SFM, 51 technologists performing FFDM, 
and 38 technologists performing both. The mean number of screening mammograms per 
year was 650.5 (range from 53.4 to 3,095.7) for technologists performing SFM exams, 872.4 
(range 52.4 to 3,433.4) for technologists performing FFDM exams, and 657.6 (range 52.4 to 
3,433.4) for technologists performing both SFM and FFDM examinations.
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The recall rate per 100 examinations was higher for FFDM compared to SFM (10.5 versus 
8.1, respectively) (Table 2). There were no significant differences in the mean sensitivity or 
mean PPV1 for SFM and FFDM. However, the specificity was lower among FFDM 
examinations compared to SFM examinations (89.8% versus 92.2%). The mean CDR per 
1000 examinations was 4.1 for FFDM and 3.8 for SFM.
Smoothed plots of model based performance measures of the studies done by technologist 
and imaging modality, adjusted for the radiologist interpreting the examination are shown in 
Figures 1–5. Each set of plots shows the range of performance measures among the studies 
done by technologists, adjusted for radiologists, for SFM (Figures 1A–5A) and FFDM 
(Figures 1B–5B). For example, in Figure 1A, sensitivity ranges from 0.66 to 0.92 among the 
studies done by technologists, with a median of 0.82, even after adjusting for the radiologist 
effect. From the figures, the variability in each performance measure is shown and suggests 
heterogeneity in the results of screening mammograms by technologist. There appears to be 
more variability in the performance measures of SFM compared with FFDM. The results of 
the likelihood ratio tests indicate that the technologists had a statistically significant effect 
on the radiologists’ recall rate, sensitivity, specificity and CDR for both SFM and FFDM (p-
values<0.01) (Table 3). For PPV1, variability by technologist was observed for SFM (p-
value<0.0001) but not FFDM (p-value=0.088).
Discussion
Interpretive performance of screening mammography is known to vary by patient (4, 23–
25), radiologist (4–7, 9, 11, 24–30) , and facility level characteristics.(30, 31) However, the 
extent to which screening mammography performance varies by the radiologic technologist 
has yet to be investigated. In this cohort study, we found significant variability in recall 
rates, sensitivity, specificity, and CDR of screening mammography by the radiologic 
technologist who did the imaging, while controlling for the radiologist interpreting the 
examination. This observed variability did not differ by imaging modality (SFM/FFDM). 
Interestingly, for PPV1 variability by technologist was observed for SFM but not FFDM.
Patient level factors that have been shown to be associated with screening mammography 
performance include age, breast density, screening history, previous biopsy, menopausal 
status, current hormone replacement therapy use, and family history of breast cancer.(4, 23, 
24) Radiologist level factors found to affect performance include time since graduation from 
residency, breast-imaging fellowship/training, annual interpretative volume, years of 
mammographic imaging and interpretation, and primary affiliation with an academic 
medical center.(4–7, 9, 24–26, 28–30) Facility level characteristics that may affect 
performance include volume, screening versus diagnostic mammography mix, having breast 
imaging specialists interpreting the examinations, and having audits two or more times per 
year.(30, 31) Despite numerous studies examining the patient, radiologist, and facility 
characteristics, variation in performance measures still exist and perhaps it is due to the 
radiologic technologist obtaining the image.
Although our study did not examine specific technologist characteristics, as it was beyond 
the scope of this paper, we suspect that technologists’ work experiences, various levels of 
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training and education, and interactions with radiologists may affect the performance of 
screening mammography in community practice. One way in which this may occur is by 
radiologic technologists assisting radiologists in the interpretation of screening 
mammograms, which has been explored in multiple studies.(13–16, 32–41) A 2006 U.S. 
study by Leader et al. examined the use of mammography technologists in providing 
limited, nonclinical interpretation of screening mammograms as part of a telemammography 
program.(32) The technologists served as pre-readers for locations with no radiologist on 
site, thus attempting to reduce the number of women recommended for additional screening 
through increased technologist and radiologist communication. The study found that 
technologists were sensitive, but not specific, to mammography features and breast changes 
that may result in recalling women for additional imaging procedures. In another U.S. study, 
33 technologists were evaluated for their ability to accurately classify screening 
mammograms as negative or requiring additional follow-up.(33) The overall agreement 
between technologists and radiologists was 82%. Although some studies have shown that 
having radiologic technologists review screening mammograms prior to the radiologist may 
increase the number of breast cancers detected, there is no consensus regarding this practice.
Radiologic technologists may also play a role in community level mammography screening 
adherence. Several focus group studies have examined this and found significant roles of the 
mammographic technologist. Patient satisfaction with the mammography experience was 
associated with treatment by the technologist in a study of 103 women in rural and urban 
communities.(42) A 2013 focus group study of 53 American Indian/Alaska native women in 
Kansas reported that having a technologist who was friendly, knowledgeable, respectful, 
competent and willing to explain the screening examination was a determining factor in 
satisfaction with mammography.(43) In another study aimed at identifying ways to increase 
patient adherence of screening mammography, survey responses suggested an expansion of 
the technologist role to that of a breast health educator, with a focus on decreasing patient 
anxiety, increasing the patient’s understanding of the procedure, and discussing the 
importance of regular screening.(44)
There is likely a learning curve for technologists as they transition from SFM to FFDM, 
similar to that observed for radiologists. To assess the impact of a 6-month learning curve on 
our results we conducted a sensitivity analysis in which we excluded FFDM examinations 
conducted in the first 6 months after a facility converted from SFM to FFDM. Variability in 
the performance measures by technologist persisted for all performance measures except 
sensitivity, which declined to non-significance (p-value from 0.027 to 0.128). This indicates 
that the technologist variability observed for sensitivity is likely attributable to the fact that 
technologists had different learning curves after the transition from SFM to FFDM.
Clearly the technologist plays a critical role in mammography screening, with the potential 
to affect the performance of radiologists’ interpretation, increase patient experience and thus 
screening adherence. Radiology technologists are required to maintain qualifications for 
performing mammographic screening. The Mammography Quality Standard Act (MQSA) 
requires that all mammographic examinations be performed by radiologic technologists who 
(1) before April 28, 1999 qualified as a radiologic technologist or (2) completed at least 40 
contact hours of documented training specific to mammography under the supervision of a 
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qualified instructor.(45) The MQSA continuing education requirements for radiologic 
technologist mammography specific training include teaching or completing at least 15 
continuing education units in mammography during the 3 years immediately preceding the 
facility’s annual MQSA inspection date.(46) Furthermore, as part of MQSA continuing 
experience requirements, radiologic technologists are required to perform a minimum of 200 
mammography examinations in the 24 months immediately preceding the date of the 
facility’s annual MQSA inspection. In contrast, MQSA requires radiologists to interpret 960 
mammograms every 2 years. Technologists who exceed the requirements may have a 
positive effect on the performance measures of the radiologists. How the technologist 
communicates and works with the radiologists is an important area for further research.
Study Limitations
Although our study includes over 350 technologists from community practice, these 
technologists are from North Carolina and thus our study results may not be generalizable to 
other geographic areas. Another limitation is that we did not take reading strategy into 
account. We do not expect this to alter our findings since only 5.9% of SFM and 0.7% of 
FFDM examinations were double read. We did not evaluate the specific technologist 
characteristics that may influence the observed variability since this information is not 
currently available. We are currently conducting a survey of mammography technologists to 
obtain data on technologist training/education, work experiences, interactions with 
radiologists, and job satisfaction for future analyses.
Conclusion
Our study findings indicate that the technologist carrying out the examination influenced 
radiologists’ recall rate, sensitivity, specificity, and CDR of screening mammography. Given 
that the technologist is an integral part of the screening mammography process, being 
responsible for positioning the patient for the examination and generating the image for the 
radiologist to interpret, our findings seem reasonable. Additional studies should aim to 
identify technologist characteristics that may explain this observed variation.
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Model-based smoothed histograms of screening mammography sensitivity for the 356 
technologists by modality (SFM and FFDM) with solid vertical lines at 25th, 50th, and 75th 
quartiles; A. SFM, B. FFDM.
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Model-based smoothed histograms of screening mammography specificity for the 356 
technologists by modality (SFM and FFDM) with solid vertical lines at 25th, 50th, and 75th 
quartiles; A. SFM, B. FFDM.
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Model-based smoothed histograms of screening mammography positive predictive value for 
the 356 technologists by modality (SFM and FFDM) with solid vertical lines at 25th, 50th, 
and 75th quartiles; A. SFM, B. FFDM.
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Model-based smoothed histograms of screening mammography recall rate for the 356 
technologists by modality (SFM and FFDM) with solid vertical lines at 25th, 50th, and 75th 
quartiles; A. SFM, B. FFDM.
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Model-based smoothed histograms of screening mammography cancer detection rate for the 
356 technologists by modality (SFM and FFDM) with solid vertical lines at 25th, 50th, and 
75th quartiles; A. SFM, B. FFDM.
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Table 3
Resulting p-values from mixed effects logistic regression models assessing variability of performance 
measures by technologist




Recall Rate <0.0001 0.001
Sensitivity <0.0001 0.019
Specificity <0.0001 0.003
Positive Predictive Value <0.0001 0.088
Cancer Detection Rate <0.0001 0.0001
SFM = screen-film mammography; FFDM = full field digital mammography
Acad Radiol. Author manuscript; available in PMC 2016 March 01.
